Centre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement. CHU de Québec
Québec, G1S 4LB, Canada
NCT Number: NCT02879084
This study investigates the variations in the retinal nerve fiber layer (RNFL) thickness during uncomplicated anterior and intermediate uveitis, respectively. The objectives are to 1 ) confirm the RNFL thickening during an uncomplicated anterior uveitis as described in the literature, 2) measure the RNFL thickness during an uncomplicated intermediate uveitis specifically and 3) describe the variation in time of RNFL thickness during the two types of uveitis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Québec, G1S 4LB, Canada
Thirty six individuals (18 with anterior uveitis and 18 with intermediate uveitis) will be recruited at the Centre universitaire d'ophtalmologie du CHU de Québec. RNFL thickness will be measured with optical coherence tomography at 3 times. For anterior uveitis, the RNFL thickness will be measured at presentation, 1 week and 4 to 6 weeks. For intermediate uveitis, the RNFL thickness will be measured at presentation, 4 to 6 weeks and 4 months. The initial thickness will be studied for each type of uveitis and progression over time will be studied also for each type of uveitis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At time 0
Time frame: At time 0
Time frame: at 4 to 6 weeks
Time frame: at 4 months
CHU de Quebec-Universite Laval
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02764697
Anterior Uveitis, Clinically Significant Macular Edema
St. Petersburg, Florida, United States
View Trial DetailsNCT01376362
Anterior Uveitis, Eye Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06679153
Anterior Uveitis, Eye Diseases
Beijing, China
View Trial DetailsNCT02725177
Anterior Uveitis, Eye Diseases
Cleveland, Ohio, United States
View Trial Details